

Prof Angela Tincani
Professor Angela Tincani is a senior consultant (previously director) at the Rheumatology and Clinical Immunology Unit of Aziende Socio Sanitaria Territoriali (ASST)-Spedali Civili and University of Brescia, Italy.
Professor Tincani has been involved in several international committees for education and research in the field of systemic autoimmune diseases. Professor Tincani’s primary clinical and research interests include the use of anti-rheumatic drugs in pregnant and lactating patients and the management of pregnancy in rheumatic disease patients, in addition to evaluating autoantibodies and autoimmune diseases as risk factors for poor gestational outcomes. She served as an expert for several European Alliance of Associations for Rheumatology (EULAR) recommendations, including “Points to consider for use of anti-rheumatic drugs before pregnancy and during pregnancy and lactation”. Together with Professor Andreoli, Professor Tincani is co-principal investigator of the “Italian Registry of Pregnancy in Rheumatic Diseases”.
This practical checklist will ensure you cover important topics with women, and that they are an active part of the decision-making process about psoriasis...
The first part of the workshop highlights the role of shared decision-making for personalised care in women of childbearing age affected by psoriasis and PsA....
The workshop highlights the challenges and treatment considerations with psoriasis and HS that go beyond the skin. Underlying disease pathophysiology, including...
In this session, the speakers highlight the importance of family planning conversations with women of childbearing age, so that appropriate treatment plans can...
The speakers discuss the potential comorbidities with rheumatoid arthritis and SpA, including cardiovascular disease and osteoporosis, and their impact on...
The speakers discuss the continued unmet needs of patients with inflammatory diseases of skin and joints in terms of treatment outcomes and health-related...